Beijing Sl Pharmaceutical Co.,Ltd. Fundamental Rankings
This page is comprehensive fundamental data for Beijing Sl Pharmaceutical Co.,Ltd.. Fundamentals are ordered by how Beijing Sl Pharmaceutical Co.,Ltd. ranks compared to other companies (ordered high to low). All money values are in CNY. All data is powered by Quandl.
Cite in Wikipedia:
| Indicator | Value | n/price | Rank | Date | Historic |
|---|---|---|---|---|---|
| Fair value change gain | 50,680,570 | 0.00288 | 30 | 2015-06-30 | historic |
| Net cash flows from investing activities | 464,020,298 | 0.02638 | 50 | 2015-06-30 | historic |
| Net change in cash | 714,939,648 | 0.04065 | 192 | 2015-06-30 | historic |
| Net income | 380,175,962 | 0.02162 | 201 | 2015-06-30 | historic |
| Interest receivable | 5,614,203 | 3.2E-4 | 204 | 2015-06-30 | historic |
| Operating profit | 430,338,155 | 0.02447 | 211 | 2015-06-30 | historic |
| Total profit | 437,887,339 | 0.0249 | 226 | 2015-06-30 | historic |
| Proceeds from sell of investment | 464,537,640 | 0.02641 | 228 | 2015-06-30 | historic |
| Total comprehensive income | 350,604,202 | 0.01993 | 258 | 2015-06-30 | historic |
| Other current liabilities | 1,350,000 | 8.0E-5 | 338 | 2015-06-30 | historic |
| Net cash and cash equivalents ending balance | 1,560,150,075 | 0.0887 | 410 | 2015-06-30 | historic |
| Long term equity investment | 137,972,112 | 0.00784 | 449 | 2015-06-30 | historic |
| Comprehensive income attributable to minority shareholders | 1,074,362 | 6.0E-5 | 534 | 2015-06-30 | historic |
| Minority interests gain | 1,074,362 | 6.0E-5 | 544 | 2015-06-30 | historic |
| Prepayment | 174,192,287 | 0.0099 | 566 | 2015-06-30 | historic |
| Cash paid for taxes | 134,765,546 | 0.00766 | 662 | 2015-06-30 | historic |
| Other current assets | 50,742,256 | 0.00289 | 697 | 2015-06-30 | historic |
| Minority interest | 34,414,111 | 0.00196 | 830 | 2015-06-30 | historic |
| Purchases of fixed assets and others | 59,471,634 | 0.00338 | 900 | 2015-06-30 | historic |
| Notes receivable | 10,265,590 | 5.8E-4 | 903 | 2015-06-30 | historic |
| Deferred tax assets | 10,012,719 | 5.7E-4 | 1084 | 2015-06-30 | historic |
| Intangible assets | 75,974,720 | 0.00432 | 1096 | 2015-06-30 | historic |
| Fixed assets | 303,254,580 | 0.01724 | 1135 | 2015-06-30 | historic |
| Cash inflows from operating activities | 648,590,934 | 0.03688 | 1137 | 2015-06-30 | historic |
| Total liabilities and equity | 3,660,139,525 | 0.2081 | 1137 | 2015-06-30 | historic |
| Total non-current assets | 1,008,152,558 | 0.05732 | 1139 | 2015-06-30 | historic |
| Non-operating loss | 90,000 | 1.0E-5 | 1159 | 2015-06-30 | historic |
| Financial expenses | -9,544,035 | -5.4E-4 | 1175 | 2015-06-30 | historic |
| Selling expenses | 12,728,872 | 7.2E-4 | 1182 | 2015-06-30 | historic |
| Revenue | 538,750,012 | 0.03063 | 1183 | 2015-06-30 | historic |
| Payroll payable | 5,365,796 | 3.1E-4 | 1208 | 2015-06-30 | historic |
| Inventories | 94,055,541 | 0.00535 | 1226 | 2015-06-30 | historic |
| Other payables | 9,215,955 | 5.2E-4 | 1230 | 2015-06-30 | historic |
| Diluted eps | 1 | 0.0 | 1232 | 2015-06-30 | historic |
| Cash outflows from operating activities | 397,570,662 | 0.0226 | 1263 | 2015-06-30 | historic |
| Accounts payable | 41,282,279 | 0.00235 | 1281 | 2015-06-30 | historic |
| Total cost of goods sold | 206,486,037 | 0.01174 | 1294 | 2015-06-30 | historic |
| Other receivables | 632,949 | 4.0E-5 | 1342 | 2015-06-30 | historic |
| Capital reserve | 7,394,192 | 4.2E-4 | 1347 | 2015-06-30 | historic |
| Total liabilities | 128,251,844 | 0.00729 | 1354 | 2015-06-30 | historic |